Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.74%

Investing.com – Denmark stocks were lower after the close on Friday, as losses in the Healthcare, Real Estate and Oil&Gas sectors led shares lower.

At the close in Copenhagen, the OMX Copenhagen 20 lost 0.74%.

The best performers of the session on the OMX Copenhagen 20 were Novozymes A/S B (CSE:NSISb), which rose 3.32% or 13.40 points to trade at 416.80 at the close. Meanwhile, Genmab (CSE:GMAB) added 2.35% or 47.00 points to end at 2,050.00 and Pandora A/S (CSE:PNDORA) was up 1.94% or 22.00 points to 1,157.50 in late trade.

The worst performers of the session were Novo Nordisk A/S Class B (CSE:NOVOb), which fell 1.59% or 14.60 points to trade at 905.00 at the close. GN Store Nord (CSE:GN) declined 0.45% or 0.70 points to end at 154.30 and Carlsberg A/S B (CSE:CARLb) was down 0.38% or 3.60 points to 942.40.

Rising stocks outnumbered declining ones on the Copenhagen Stock Exchange by 80 to 67 and 14 ended unchanged.

Shares in Novozymes A/S B (CSE:NSISb) rose to 52-week highs; gaining 3.32% or 13.40 to 416.80. Shares in Pandora A/S (CSE:PNDORA) rose to all time highs; gaining 1.94% or 22.00 to 1,157.50.

Crude oil for April delivery was down 1.22% or 0.96 to $77.97 a barrel. Elsewhere in commodities trading, Brent oil for delivery in May fell 1.02% or 0.85 to hit $82.11 a barrel, while the April Gold Futures contract rose 0.76% or 16.35 to trade at $2,181.55 a troy ounce.

USD/DKK was unchanged 0.05% to 6.81, while EUR/DKK unchanged 0.01% to 7.45.

The US Dollar Index Futures was down 0.08% at 102.69.